Skip to main content
. Author manuscript; available in PMC: 2018 Jan 22.
Published in final edited form as: Cancer Prev Res (Phila). 2016 Apr 12;9(7):558–566. doi: 10.1158/1940-6207.CAPR-15-0379

Figure 4.

Figure 4

IHC staining extent scoring for putative genes across matched and dysplastic cohorts of samples. The number of samples in each pathology group is noted above each column. The ‘normal’ group is comprised of NT samples from the matched cohort and NE samples from the dysplastic cohort.